Intuitive Surgical, Inc. $ISRG Shares Sold by Global Retirement Partners LLC

Global Retirement Partners LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 13.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 23,044 shares of the medical equipment provider’s stock after selling 3,443 shares during the quarter. Global Retirement Partners LLC’s holdings in Intuitive Surgical were worth $9,370,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of ISRG. Bank of America Corp DE boosted its holdings in shares of Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after purchasing an additional 116,292 shares during the period. Bank of New York Mellon Corp purchased a new position in shares of Intuitive Surgical during the second quarter worth approximately $1,335,753,000. Amundi lifted its holdings in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after buying an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership raised its holdings in shares of Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Intuitive Surgical by 10.8% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after acquiring an additional 184,044 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Top Intuitive Surgical Stories

Investors following ISRG have been watching these stories:

  • Positive Sentiment: Recent coverage highlights adjusted EPS growth of 25%, supported by robotic-platform adoption and AI-related innovation. This suggests strong demand and continued earnings growth, though higher R&D costs and a litigation settlement are offsets. ISRG EPS and innovation article
  • Neutral Sentiment: EVP Mark Brosius reported sales totaling 92 shares across two transactions, worth about $40,250. Both were made under a pre-arranged Rule 10b5-1 plan, and the small size makes them a limited signal about management’s view of the stock. SEC insider-trading filing
  • Negative Sentiment: A valuation-focused analysis argues ISRG may be near fair value despite revenue growth, pointing to competitive pressure and new robotic platforms. That may temper enthusiasm for the shares after their longer-term gains. Valuation and competition analysis

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $420.95 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The stock’s 50-day moving average is $421.98 and its 200 day moving average is $428.75. The company has a market cap of $145.92 billion, a P/E ratio of 50.90, a PEG ratio of 2.97 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping the consensus estimate of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. Intuitive Surgical’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.40 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Insiders Place Their Bets

In other news, Director Craig Barratt sold 1,150 shares of the company’s stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total transaction of $529,000.00. Following the transaction, the director directly owned 1,150 shares of the company’s stock, valued at approximately $529,000. This represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total value of $183,260.00. Following the sale, the executive vice president owned 6,236 shares of the company’s stock, valued at approximately $2,857,023.40. This represents a 6.03% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 39,394 shares of company stock valued at $17,748,935. 0.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on ISRG shares. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $486.00 price objective (down from $487.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. JPMorgan Chase & Co. boosted their price target on shares of Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a report on Wednesday, October 21st. Royal Bank Of Canada lowered their price target on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research report on Wednesday, October 21st. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday, October 21st. Finally, BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $495.90.

View Our Latest Stock Report on Intuitive Surgical

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.